AVDL
Avadel Pharmaceuticals
AVDL
AVDL
170 hedge funds and large institutions have $719M invested in Avadel Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 70 increasing their positions, 49 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
-2
Holders Change %
-1.16%
% of All Funds
2.28%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
70
Reduced
49
Closed
27
Calls
$2.43M
Puts
$3.91M
Net Calls
-$1.48M
Net Calls Change
+$257K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$49.2M |
| 2 |
BlackRock
New York
|
$60.2M |
| 3 |
TSC
Two Seas Capital
Rye,
New York
|
$54.5M |
| 4 |
TLP
Tri Locum Partners
New York
|
$8.98M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$19.2M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$98.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
$1.28M |
| 3 |
GJL
Gendell Jeffrey L
|
$45.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$13.5M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$7.75M |
